Debut

Debut is building the future of beauty with cutting-edge AI and biotechnology, creating high-performing, innovative ingredients and formulations that propel the industry forward. The company specializes in scientifically-discovered, clinically-proven and inherently sustainable ingredients that provide maximum efficacy.

Health and bio

Debut raised $20M in a funding round announced August 26, 2025, according to finsmes.com. Investors in that round: F-Prime Capital.

Raise history

1. September 29, 2026
   First seen by Recent Funding
   via startups.gallery
2. August 26, 2025
   Round · $20M
   FF-Prime Capital (lead)
   Source: finsmes.com (startups.gallery listing)

Investors

• FF-Prime Capital
• GGS Futures

Related other companies

• QQuartermaster$140M · Sep 28, 2026
• SSnorkel AI$350M · Sep 23, 2026
• EEnveda$311M · Sep 23, 2026
• HHeidi Health$100M · Sep 22, 2026
• FFirecrawl$75M · Sep 22, 2026
• CCorridor$25M · Sep 21, 2026
• JJack & Jill$40M · Sep 19, 2026
• MMithr Inc.$20M · Sep 19, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/debut.